Brasil
Hematology, Transfusion and Cell Therapy
Tabla de contenido Anterior Actual Siguiente
Tabla de contenido
Special article • Hematol., Transfus. Cell Ther. 42 (2) • Apr-Jun 2020 • https://doi.org/10.1016/j.htct.2020.04.002 linkcopy

Open-access How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation

AuthorshipSCIMAGO INSTITUTIONS RANKINGS

The novel Coronavirus (CoVid-19) outbreak is now consider a world pandemic, affecting more than 1,300,000 people worldwide. Cancer patients are in risk for severe disease, including a higher risk of intensive care unit (ICU) admission, need for invasive ventilation or death. Management of patients with lymphoid malignancies can be challenging during the outbreak, due to need of multiple hospital visits and admissions, immunosuppression and need for chemotherapy, radiotherapy and stem cell transplantation. In this article, we will focus on the practical management of patients with lymphoid malignancies during the COVID-19 pandemic, focusing on minimizing the risk for patients.

Keywords
CoVid; CoVId-19; Coronavirus; Lymphoma; Chronic lymphocytic leukemia; Lymphoid malignancies

location_on
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH) R. Dr. Diogo de Faria, 775 cj 133, 04037-002, São Paulo / SP - Brasil - São Paulo - SP - Brazil
E-mail: htct@abhh.org.br
rss_feed Acompañe los números de esta revista en su lector de RSS
Notificar error